Non‐high‐density lipoprotein cholesterol is more informative than traditional cholesterol indices in predicting diabetes risk for women with normal glucose tolerance

Aims/Introduction Limited data are available regarding the performance of non‐high‐density lipoprotein cholesterol (non‐HDL) in predicting incident diabetes. We aimed to analyze the association between non‐HDL and development of diabetes, and to estimate the cut‐off point of non‐HDL for discriminati...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of diabetes investigation 2018-11, Vol.9 (6), p.1304-1311
Hauptverfasser: Liu, Lu, Li, Qiu, Yuan, Zhongshang, Zhao, Meng, Zhang, Xu, Zhang, Haiqing, Zheng, Dongmei, Xu, Jin, Gao, Ling, Guan, Qingbo, Zhao, Jiajun, Proud, Christopher G, Wang, Xuemin, Hou, Xu
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1311
container_issue 6
container_start_page 1304
container_title Journal of diabetes investigation
container_volume 9
creator Liu, Lu
Li, Qiu
Yuan, Zhongshang
Zhao, Meng
Zhang, Xu
Zhang, Haiqing
Zheng, Dongmei
Xu, Jin
Gao, Ling
Guan, Qingbo
Zhao, Jiajun
Proud, Christopher G
Wang, Xuemin
Hou, Xu
description Aims/Introduction Limited data are available regarding the performance of non‐high‐density lipoprotein cholesterol (non‐HDL) in predicting incident diabetes. We aimed to analyze the association between non‐HDL and development of diabetes, and to estimate the cut‐off point of non‐HDL for discriminating incident diabetes in people with normal glucose tolerance. Materials and Methods Of 3,653 middle‐aged and elderly Chinese with normal glucose tolerance at enrollment, 1,025 men and 1,805 women returned to the 3‐year follow up and were involved in the final analysis. Logistic regression analysis was used to test the association between cholesterol indices and incident diabetes, and receiver operating characteristic analyses were used to identify the optimal cut‐off of each cholesterol variable for incident diabetes. Results Non‐HDL was an independent risk factor for diabetes for women, but not for men. In women, a 1‐standard deviation increment in non‐HDL was associated with a 1.43‐fold higher risk of diabetes (95% confidence interval 1.14–1.79; P = 0.002), whereas odds ratios for total cholesterol and low‐density lipoprotein cholesterol were 1.33 (95% confidence interval 1.06–1.67; P = 0.015) and 1.30 (95% confidence interval 1.04–1.64; P = 0.024), respectively. The discriminatory power and the optimal cut‐off value of non‐HDL for incident diabetes increased across body mass index categories. For women with obesity, the threshold of non‐HDL for screening of diabetes was estimated as 3.51 mmol/L. Conclusions Non‐HDL had better performance than traditional cholesterol indices in predicting diabetes in women, but not in men. A body mass index‐specific threshold value for a non‐HDL‐controlling target is required in the prevention of type 2 diabetes.
doi_str_mv 10.1111/jdi.12837
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6215933</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2129354141</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4957-cb3c27e9997646862463486a5f740db82484c9b81249818615a1a03d889c8efd3</originalsourceid><addsrcrecordid>eNp1ks1u1DAQgCMEolXpgRdAlrjAYdvYcRL7goTKX1EFFzhbjjPZeHHsYDtd7Y1H4DV4LZ6EKVtWFIm5jGV__jQeT1E8puUZxTjf9PaMMlG194pjVvJyRSnj9w9r2hwVpyltSoxKiKZpHxZHTNacMSGOix8fgv_57fto1yOmHnyyeUecncMcQwbriRmDg5QhBkdsIlOIQKwfQpx0ttdA8qg9yVH3Ntvgtbt7wffWQMJM5gi4ztavSW91Bxm3o01fCKrINkzgydbmkfgbsyNrt5iQUI-yqL2BR8WDQbsEp7f5pPj85vWni3erq49vLy9eXq0Ml3W7Ml1lWAtSyrbhjWgYbyouGl0PLS_7TjAuuJGdwCZJQUVDa011WfVCSCNg6KuT4sXeOy_dBL0Bj49zao520nGngrbq7om3o1qHa9UwWsuqQsGzW0EMXxfshJpsMuCc9hCWpFhJOeVMyhLRp_-gm7BEbCJSlMmqRpAi9XxPmRhSijAciqGlupkBhTOgfs8Ask_-rv5A_vlxBM73wNY62P3fpN6_utwrfwFUecFE</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2129354141</pqid></control><display><type>article</type><title>Non‐high‐density lipoprotein cholesterol is more informative than traditional cholesterol indices in predicting diabetes risk for women with normal glucose tolerance</title><source>MEDLINE</source><source>Wiley Online Library Open Access</source><source>DOAJ Directory of Open Access Journals</source><source>Wiley Online Library Journals Frontfile Complete</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><creator>Liu, Lu ; Li, Qiu ; Yuan, Zhongshang ; Zhao, Meng ; Zhang, Xu ; Zhang, Haiqing ; Zheng, Dongmei ; Xu, Jin ; Gao, Ling ; Guan, Qingbo ; Zhao, Jiajun ; Proud, Christopher G ; Wang, Xuemin ; Hou, Xu</creator><creatorcontrib>Liu, Lu ; Li, Qiu ; Yuan, Zhongshang ; Zhao, Meng ; Zhang, Xu ; Zhang, Haiqing ; Zheng, Dongmei ; Xu, Jin ; Gao, Ling ; Guan, Qingbo ; Zhao, Jiajun ; Proud, Christopher G ; Wang, Xuemin ; Hou, Xu ; REACTION Study Group ; The REACTION Study Group</creatorcontrib><description>Aims/Introduction Limited data are available regarding the performance of non‐high‐density lipoprotein cholesterol (non‐HDL) in predicting incident diabetes. We aimed to analyze the association between non‐HDL and development of diabetes, and to estimate the cut‐off point of non‐HDL for discriminating incident diabetes in people with normal glucose tolerance. Materials and Methods Of 3,653 middle‐aged and elderly Chinese with normal glucose tolerance at enrollment, 1,025 men and 1,805 women returned to the 3‐year follow up and were involved in the final analysis. Logistic regression analysis was used to test the association between cholesterol indices and incident diabetes, and receiver operating characteristic analyses were used to identify the optimal cut‐off of each cholesterol variable for incident diabetes. Results Non‐HDL was an independent risk factor for diabetes for women, but not for men. In women, a 1‐standard deviation increment in non‐HDL was associated with a 1.43‐fold higher risk of diabetes (95% confidence interval 1.14–1.79; P = 0.002), whereas odds ratios for total cholesterol and low‐density lipoprotein cholesterol were 1.33 (95% confidence interval 1.06–1.67; P = 0.015) and 1.30 (95% confidence interval 1.04–1.64; P = 0.024), respectively. The discriminatory power and the optimal cut‐off value of non‐HDL for incident diabetes increased across body mass index categories. For women with obesity, the threshold of non‐HDL for screening of diabetes was estimated as 3.51 mmol/L. Conclusions Non‐HDL had better performance than traditional cholesterol indices in predicting diabetes in women, but not in men. A body mass index‐specific threshold value for a non‐HDL‐controlling target is required in the prevention of type 2 diabetes.</description><identifier>ISSN: 2040-1116</identifier><identifier>EISSN: 2040-1124</identifier><identifier>DOI: 10.1111/jdi.12837</identifier><identifier>PMID: 29542288</identifier><language>eng</language><publisher>Japan: John Wiley &amp; Sons, Inc</publisher><subject>Body mass index ; Cholesterol ; Cholesterol - analysis ; Cholesterol - blood ; Confidence intervals ; Diabetes ; Diabetes mellitus ; Diabetes mellitus (non-insulin dependent) ; Diabetes Mellitus - blood ; Diabetes Mellitus - diagnosis ; Female ; Geriatrics ; Glucose tolerance ; Health risk assessment ; High density lipoprotein ; Humans ; Lipoproteins ; Lipoproteins - analysis ; Lipoproteins - blood ; Male ; Middle Aged ; Non‐high‐density lipoprotein cholesterol ; Original ; Primary prevention ; Prospective Studies ; Risk Factors ; ROC Curve ; Type 2 diabetes</subject><ispartof>Journal of diabetes investigation, 2018-11, Vol.9 (6), p.1304-1311</ispartof><rights>2018 The Authors. Journal of Diabetes Investigation published by Asian Association for the Study of Diabetes (AASD) and John Wiley &amp; Sons Australia, Ltd</rights><rights>2018 The Authors. Journal of Diabetes Investigation published by Asian Association for the Study of Diabetes (AASD) and John Wiley &amp; Sons Australia, Ltd.</rights><rights>2018. This work is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4957-cb3c27e9997646862463486a5f740db82484c9b81249818615a1a03d889c8efd3</citedby><cites>FETCH-LOGICAL-c4957-cb3c27e9997646862463486a5f740db82484c9b81249818615a1a03d889c8efd3</cites><orcidid>0000-0002-9884-584X</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6215933/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6215933/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,860,881,1411,11541,27901,27902,45550,45551,46027,46451,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/29542288$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Liu, Lu</creatorcontrib><creatorcontrib>Li, Qiu</creatorcontrib><creatorcontrib>Yuan, Zhongshang</creatorcontrib><creatorcontrib>Zhao, Meng</creatorcontrib><creatorcontrib>Zhang, Xu</creatorcontrib><creatorcontrib>Zhang, Haiqing</creatorcontrib><creatorcontrib>Zheng, Dongmei</creatorcontrib><creatorcontrib>Xu, Jin</creatorcontrib><creatorcontrib>Gao, Ling</creatorcontrib><creatorcontrib>Guan, Qingbo</creatorcontrib><creatorcontrib>Zhao, Jiajun</creatorcontrib><creatorcontrib>Proud, Christopher G</creatorcontrib><creatorcontrib>Wang, Xuemin</creatorcontrib><creatorcontrib>Hou, Xu</creatorcontrib><creatorcontrib>REACTION Study Group</creatorcontrib><creatorcontrib>The REACTION Study Group</creatorcontrib><title>Non‐high‐density lipoprotein cholesterol is more informative than traditional cholesterol indices in predicting diabetes risk for women with normal glucose tolerance</title><title>Journal of diabetes investigation</title><addtitle>J Diabetes Investig</addtitle><description>Aims/Introduction Limited data are available regarding the performance of non‐high‐density lipoprotein cholesterol (non‐HDL) in predicting incident diabetes. We aimed to analyze the association between non‐HDL and development of diabetes, and to estimate the cut‐off point of non‐HDL for discriminating incident diabetes in people with normal glucose tolerance. Materials and Methods Of 3,653 middle‐aged and elderly Chinese with normal glucose tolerance at enrollment, 1,025 men and 1,805 women returned to the 3‐year follow up and were involved in the final analysis. Logistic regression analysis was used to test the association between cholesterol indices and incident diabetes, and receiver operating characteristic analyses were used to identify the optimal cut‐off of each cholesterol variable for incident diabetes. Results Non‐HDL was an independent risk factor for diabetes for women, but not for men. In women, a 1‐standard deviation increment in non‐HDL was associated with a 1.43‐fold higher risk of diabetes (95% confidence interval 1.14–1.79; P = 0.002), whereas odds ratios for total cholesterol and low‐density lipoprotein cholesterol were 1.33 (95% confidence interval 1.06–1.67; P = 0.015) and 1.30 (95% confidence interval 1.04–1.64; P = 0.024), respectively. The discriminatory power and the optimal cut‐off value of non‐HDL for incident diabetes increased across body mass index categories. For women with obesity, the threshold of non‐HDL for screening of diabetes was estimated as 3.51 mmol/L. Conclusions Non‐HDL had better performance than traditional cholesterol indices in predicting diabetes in women, but not in men. A body mass index‐specific threshold value for a non‐HDL‐controlling target is required in the prevention of type 2 diabetes.</description><subject>Body mass index</subject><subject>Cholesterol</subject><subject>Cholesterol - analysis</subject><subject>Cholesterol - blood</subject><subject>Confidence intervals</subject><subject>Diabetes</subject><subject>Diabetes mellitus</subject><subject>Diabetes mellitus (non-insulin dependent)</subject><subject>Diabetes Mellitus - blood</subject><subject>Diabetes Mellitus - diagnosis</subject><subject>Female</subject><subject>Geriatrics</subject><subject>Glucose tolerance</subject><subject>Health risk assessment</subject><subject>High density lipoprotein</subject><subject>Humans</subject><subject>Lipoproteins</subject><subject>Lipoproteins - analysis</subject><subject>Lipoproteins - blood</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Non‐high‐density lipoprotein cholesterol</subject><subject>Original</subject><subject>Primary prevention</subject><subject>Prospective Studies</subject><subject>Risk Factors</subject><subject>ROC Curve</subject><subject>Type 2 diabetes</subject><issn>2040-1116</issn><issn>2040-1124</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><sourceid>24P</sourceid><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNp1ks1u1DAQgCMEolXpgRdAlrjAYdvYcRL7goTKX1EFFzhbjjPZeHHsYDtd7Y1H4DV4LZ6EKVtWFIm5jGV__jQeT1E8puUZxTjf9PaMMlG194pjVvJyRSnj9w9r2hwVpyltSoxKiKZpHxZHTNacMSGOix8fgv_57fto1yOmHnyyeUecncMcQwbriRmDg5QhBkdsIlOIQKwfQpx0ttdA8qg9yVH3Ntvgtbt7wffWQMJM5gi4ztavSW91Bxm3o01fCKrINkzgydbmkfgbsyNrt5iQUI-yqL2BR8WDQbsEp7f5pPj85vWni3erq49vLy9eXq0Ml3W7Ml1lWAtSyrbhjWgYbyouGl0PLS_7TjAuuJGdwCZJQUVDa011WfVCSCNg6KuT4sXeOy_dBL0Bj49zao520nGngrbq7om3o1qHa9UwWsuqQsGzW0EMXxfshJpsMuCc9hCWpFhJOeVMyhLRp_-gm7BEbCJSlMmqRpAi9XxPmRhSijAciqGlupkBhTOgfs8Ask_-rv5A_vlxBM73wNY62P3fpN6_utwrfwFUecFE</recordid><startdate>201811</startdate><enddate>201811</enddate><creator>Liu, Lu</creator><creator>Li, Qiu</creator><creator>Yuan, Zhongshang</creator><creator>Zhao, Meng</creator><creator>Zhang, Xu</creator><creator>Zhang, Haiqing</creator><creator>Zheng, Dongmei</creator><creator>Xu, Jin</creator><creator>Gao, Ling</creator><creator>Guan, Qingbo</creator><creator>Zhao, Jiajun</creator><creator>Proud, Christopher G</creator><creator>Wang, Xuemin</creator><creator>Hou, Xu</creator><general>John Wiley &amp; Sons, Inc</general><general>John Wiley and Sons Inc</general><scope>24P</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7T5</scope><scope>7TM</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>H94</scope><scope>K9.</scope><scope>M0S</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-9884-584X</orcidid></search><sort><creationdate>201811</creationdate><title>Non‐high‐density lipoprotein cholesterol is more informative than traditional cholesterol indices in predicting diabetes risk for women with normal glucose tolerance</title><author>Liu, Lu ; Li, Qiu ; Yuan, Zhongshang ; Zhao, Meng ; Zhang, Xu ; Zhang, Haiqing ; Zheng, Dongmei ; Xu, Jin ; Gao, Ling ; Guan, Qingbo ; Zhao, Jiajun ; Proud, Christopher G ; Wang, Xuemin ; Hou, Xu</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4957-cb3c27e9997646862463486a5f740db82484c9b81249818615a1a03d889c8efd3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Body mass index</topic><topic>Cholesterol</topic><topic>Cholesterol - analysis</topic><topic>Cholesterol - blood</topic><topic>Confidence intervals</topic><topic>Diabetes</topic><topic>Diabetes mellitus</topic><topic>Diabetes mellitus (non-insulin dependent)</topic><topic>Diabetes Mellitus - blood</topic><topic>Diabetes Mellitus - diagnosis</topic><topic>Female</topic><topic>Geriatrics</topic><topic>Glucose tolerance</topic><topic>Health risk assessment</topic><topic>High density lipoprotein</topic><topic>Humans</topic><topic>Lipoproteins</topic><topic>Lipoproteins - analysis</topic><topic>Lipoproteins - blood</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Non‐high‐density lipoprotein cholesterol</topic><topic>Original</topic><topic>Primary prevention</topic><topic>Prospective Studies</topic><topic>Risk Factors</topic><topic>ROC Curve</topic><topic>Type 2 diabetes</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Liu, Lu</creatorcontrib><creatorcontrib>Li, Qiu</creatorcontrib><creatorcontrib>Yuan, Zhongshang</creatorcontrib><creatorcontrib>Zhao, Meng</creatorcontrib><creatorcontrib>Zhang, Xu</creatorcontrib><creatorcontrib>Zhang, Haiqing</creatorcontrib><creatorcontrib>Zheng, Dongmei</creatorcontrib><creatorcontrib>Xu, Jin</creatorcontrib><creatorcontrib>Gao, Ling</creatorcontrib><creatorcontrib>Guan, Qingbo</creatorcontrib><creatorcontrib>Zhao, Jiajun</creatorcontrib><creatorcontrib>Proud, Christopher G</creatorcontrib><creatorcontrib>Wang, Xuemin</creatorcontrib><creatorcontrib>Hou, Xu</creatorcontrib><creatorcontrib>REACTION Study Group</creatorcontrib><creatorcontrib>The REACTION Study Group</creatorcontrib><collection>Wiley Online Library Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Immunology Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of diabetes investigation</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Liu, Lu</au><au>Li, Qiu</au><au>Yuan, Zhongshang</au><au>Zhao, Meng</au><au>Zhang, Xu</au><au>Zhang, Haiqing</au><au>Zheng, Dongmei</au><au>Xu, Jin</au><au>Gao, Ling</au><au>Guan, Qingbo</au><au>Zhao, Jiajun</au><au>Proud, Christopher G</au><au>Wang, Xuemin</au><au>Hou, Xu</au><aucorp>REACTION Study Group</aucorp><aucorp>The REACTION Study Group</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Non‐high‐density lipoprotein cholesterol is more informative than traditional cholesterol indices in predicting diabetes risk for women with normal glucose tolerance</atitle><jtitle>Journal of diabetes investigation</jtitle><addtitle>J Diabetes Investig</addtitle><date>2018-11</date><risdate>2018</risdate><volume>9</volume><issue>6</issue><spage>1304</spage><epage>1311</epage><pages>1304-1311</pages><issn>2040-1116</issn><eissn>2040-1124</eissn><abstract>Aims/Introduction Limited data are available regarding the performance of non‐high‐density lipoprotein cholesterol (non‐HDL) in predicting incident diabetes. We aimed to analyze the association between non‐HDL and development of diabetes, and to estimate the cut‐off point of non‐HDL for discriminating incident diabetes in people with normal glucose tolerance. Materials and Methods Of 3,653 middle‐aged and elderly Chinese with normal glucose tolerance at enrollment, 1,025 men and 1,805 women returned to the 3‐year follow up and were involved in the final analysis. Logistic regression analysis was used to test the association between cholesterol indices and incident diabetes, and receiver operating characteristic analyses were used to identify the optimal cut‐off of each cholesterol variable for incident diabetes. Results Non‐HDL was an independent risk factor for diabetes for women, but not for men. In women, a 1‐standard deviation increment in non‐HDL was associated with a 1.43‐fold higher risk of diabetes (95% confidence interval 1.14–1.79; P = 0.002), whereas odds ratios for total cholesterol and low‐density lipoprotein cholesterol were 1.33 (95% confidence interval 1.06–1.67; P = 0.015) and 1.30 (95% confidence interval 1.04–1.64; P = 0.024), respectively. The discriminatory power and the optimal cut‐off value of non‐HDL for incident diabetes increased across body mass index categories. For women with obesity, the threshold of non‐HDL for screening of diabetes was estimated as 3.51 mmol/L. Conclusions Non‐HDL had better performance than traditional cholesterol indices in predicting diabetes in women, but not in men. A body mass index‐specific threshold value for a non‐HDL‐controlling target is required in the prevention of type 2 diabetes.</abstract><cop>Japan</cop><pub>John Wiley &amp; Sons, Inc</pub><pmid>29542288</pmid><doi>10.1111/jdi.12837</doi><tpages>8</tpages><orcidid>https://orcid.org/0000-0002-9884-584X</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2040-1116
ispartof Journal of diabetes investigation, 2018-11, Vol.9 (6), p.1304-1311
issn 2040-1116
2040-1124
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6215933
source MEDLINE; Wiley Online Library Open Access; DOAJ Directory of Open Access Journals; Wiley Online Library Journals Frontfile Complete; EZB-FREE-00999 freely available EZB journals; PubMed Central
subjects Body mass index
Cholesterol
Cholesterol - analysis
Cholesterol - blood
Confidence intervals
Diabetes
Diabetes mellitus
Diabetes mellitus (non-insulin dependent)
Diabetes Mellitus - blood
Diabetes Mellitus - diagnosis
Female
Geriatrics
Glucose tolerance
Health risk assessment
High density lipoprotein
Humans
Lipoproteins
Lipoproteins - analysis
Lipoproteins - blood
Male
Middle Aged
Non‐high‐density lipoprotein cholesterol
Original
Primary prevention
Prospective Studies
Risk Factors
ROC Curve
Type 2 diabetes
title Non‐high‐density lipoprotein cholesterol is more informative than traditional cholesterol indices in predicting diabetes risk for women with normal glucose tolerance
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-05T11%3A33%3A30IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Non%E2%80%90high%E2%80%90density%20lipoprotein%20cholesterol%20is%20more%20informative%20than%20traditional%20cholesterol%20indices%20in%20predicting%20diabetes%20risk%20for%20women%20with%20normal%20glucose%20tolerance&rft.jtitle=Journal%20of%20diabetes%20investigation&rft.au=Liu,%20Lu&rft.aucorp=REACTION%20Study%20Group&rft.date=2018-11&rft.volume=9&rft.issue=6&rft.spage=1304&rft.epage=1311&rft.pages=1304-1311&rft.issn=2040-1116&rft.eissn=2040-1124&rft_id=info:doi/10.1111/jdi.12837&rft_dat=%3Cproquest_pubme%3E2129354141%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2129354141&rft_id=info:pmid/29542288&rfr_iscdi=true